Cargando…
Recent advances in understanding and managing Crohn’s disease
There is consensus that inflammatory bowel diseases (IBDs) are the result of “dysregulated” immune reactivity towards commensal microorganisms in the intestine. This gut microbiome is clearly altered in IBD, but its primary or secondary role is still debated. The focus has shifted from adaptive to i...
Autores principales: | Stange, Eduard F., Wehkamp, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5271584/ https://www.ncbi.nlm.nih.gov/pubmed/28163902 http://dx.doi.org/10.12688/f1000research.9890.1 |
Ejemplares similares
-
Recent advances and emerging therapies in the non-surgical management of ulcerative colitis
por: Wehkamp, Jan, et al.
Publicado: (2018) -
Medical Therapy of Perianal Crohn's Disease
por: Klag, Thomas, et al.
Publicado: (2015) -
An Update Review on the Paneth Cell as Key to Ileal Crohn's Disease
por: Wehkamp, Jan, et al.
Publicado: (2020) -
In the Wnt of Paneth Cells: Immune-Epithelial Crosstalk in Small Intestinal Crohn’s Disease
por: Armbruster, Nicole S., et al.
Publicado: (2017) -
Influence of NOD2 Variants on Trichuris suis ova Treatment Outcome in Crohn’s Disease
por: Jaeger, Simon U., et al.
Publicado: (2018)